Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
Puig N, Hernández MT, Rosiñol L, González E, de Arriba F, Oriol A, González-Calle V, Escalante F, de la Rubia J, Gironella M, Ríos R, García-Sánchez R, Arguiñano JM, Alegre A, Martín J, Gutiérrez NC, Calasanz MJ, Martín ML, Couto MDC, Casanova M, Arnao M, Pérez-Persona E, Garzón S, González MS, Martín-Sánchez G, Ocio EM, Coleman M, Encinas C, Vale AM, Teruel AI, Cortés-Rodríguez M, Paiva B, Cedena MT, San-Miguel JF, Lahuerta JJ, Bladé J, Niesvizky R, Mateos MV. Puig N, et al. Among authors: gonzalez e, gonzalez ms, gonzalez calle v. Blood Cancer J. 2021 May 21;11(5):101. doi: 10.1038/s41408-021-00490-8. Blood Cancer J. 2021. PMID: 34021118 Free PMC article. Clinical Trial.
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.
Cejalvo MJ, Bustamante G, González E, Vázquez-Álvarez J, García R, Ramírez-Payer Á, Pérez-Persona E, Abella E, Garzón S, García A, Jarque I, González MS, Sampol A, Motlló C, Martí JM, Alcalá M, Duro R, González Y, Sastre JL, Sarrà J, Lostaunau G, López R, de la Rubia J. Cejalvo MJ, et al. Among authors: gonzalez e, gonzalez ms, gonzalez y. Ann Hematol. 2021 Jul;100(7):1769-1778. doi: 10.1007/s00277-021-04529-5. Epub 2021 Apr 22. Ann Hematol. 2021. PMID: 33885924
Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study.
Ocio EM, Montes-Gaisán C, Bustamante G, Garzón S, González E, Pérez E, Sirvent M, Arguiñano JM, González Y, Ríos R, de Miguel D, Grande M, Fernández A, Naves A, Rosiñol L. Ocio EM, et al. Among authors: gonzalez e, gonzalez y. Clin Lymphoma Myeloma Leuk. 2022 Apr;22(4):e241-e249. doi: 10.1016/j.clml.2021.10.001. Epub 2021 Oct 8. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34774462 Free article.
Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain.
Pérez-Jacoiste Asín MA, Carrasco-Antón N, Fernández-Ruiz M, San Juan R, Alonso-Moralejo R, González E, Andrés A, López-Medrano F, Aguado JM. Pérez-Jacoiste Asín MA, et al. Among authors: gonzalez e. Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12623. Epub 2017 Jan 3. Transpl Infect Dis. 2017. PMID: 27768239
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C, Calvo Rodríguez M, Poveda JL, Pascual J, Crespo M, Gomez G, Cabello Pelegrin S, Paul J, Lauzurica R, Perez Mir M, Moreso F, Perelló M, Andres A, González E, Fernandez A, Mendiluce A, Fernández Carbajo B, Sanchez Fructuoso A, Calvo N, Suarez A, Bernal Blanco G, Osuna A, Ruiz-Fuentes MC, Melilli E, Montero Perez N, Ramos A, Fernández B, López V, Hernandez D; Better study. Fernandez Rivera C, et al. Among authors: gonzalez e. Clin Transplant. 2022 Mar;36(3):e14550. doi: 10.1111/ctr.14550. Epub 2021 Dec 17. Clin Transplant. 2022. PMID: 34851532 Free PMC article.
Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates.
Fernández-Ruiz M, Forque L, Albert E, Redondo N, Giménez E, López-Medrano F, González E, Polanco N, Ruiz-Merlo T, Parra P, San Juan R, Andrés A, Aguado JM, Navarro D. Fernández-Ruiz M, et al. Among authors: gonzalez e. Transpl Infect Dis. 2022 Feb;24(1):e13771. doi: 10.1111/tid.13771. Epub 2021 Dec 29. Transpl Infect Dis. 2022. PMID: 34921747
Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus.
González-Roncero FM, Gentil-Govantes MÁ, González-Molina M, Rivero M, Cantarell C, Alarcón A, Franco A, Sánchez-Plumed J, Lampreabe I, Lauzurica R, González E, Romero R, Ruiz-San Millán JC, Osuna A. González-Roncero FM, et al. Among authors: gonzalez molina m, gonzalez e. Nefrologia. 2012 Jul 17;32(4):446-54. doi: 10.3265/Nefrologia.pre2012.Mar.11024. Nefrologia. 2012. PMID: 22806279 Free article. English, Spanish.
Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin.
Fernández-Ruiz M, Rodríguez-Goncer I, Parra P, Ruiz-Merlo T, Corbella L, López-Medrano F, Polanco N, González E, San Juan R, Folgueira MD, Andrés A, Aguado JM. Fernández-Ruiz M, et al. Among authors: gonzalez e. Am J Transplant. 2020 Aug;20(8):2070-2080. doi: 10.1111/ajt.15793. Epub 2020 Feb 21. Am J Transplant. 2020. PMID: 31991045 Free article.
SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19.
Fernández-Ruiz M, Olea B, Giménez E, Laguna-Goya R, Trujillo H, Caravaca-Fontán F, Gutiérrez E, López-Medrano F, Remigia MJ, Almendro-Vazquez P, Polanco N, González E, Ruiz-Merlo T, Parra P, San Juan R, Andrés A, Navarro D, Aguado JM. Fernández-Ruiz M, et al. Among authors: gonzalez e. Transplantation. 2021 Jun 1;105(6):1372-1380. doi: 10.1097/TP.0000000000003672. Transplantation. 2021. PMID: 33729741
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients.
Villanego F, Mazuecos A, Cubillo B, Merino MJ, Poveda I, Saura IM, Segurado Ó, Cruzado L, Eady M, Zárraga S, Aladrén MJ, Cabello S, López V, González E, Lorenzo I, Espí-Reig J, Fernández C, Osma J, Ruiz-Fuentes MC, Toapanta N, Franco A, Burballa CC, Muñoz MA, Crespo M, Pascual J. Villanego F, et al. Among authors: gonzalez e. Clin Kidney J. 2022 Jul 28;15(10):1847-1855. doi: 10.1093/ckj/sfac177. eCollection 2022 Oct. Clin Kidney J. 2022. PMID: 36147706 Free PMC article.
3,102 results